Search
for

    GlossaryCutaneous Side Effects (Skin Adverse Events)

    ...skin reactions caused by medications or treatments

    Cutaneous side effects refer to adverse reactions that affect the skin as a result of medication, treatment, or other external factors. These can include rashes, itching, redness, and more severe conditions like blistering or peeling. For professionals, understanding these side effects is crucial for diagnosing and managing patient care, especially in treatments involving chemotherapy or immunotherapy, which are known to cause significant skin reactions.

    Related Terms

    Learn

    5 / 28 results

      learn Follistatin

      glycoprotein that inhibits TGF-β and promotes hair growth by antagonizing activin

      learn Microneedling

      technique to create small wounds in skin to activate collagen production and hair growth

      learn Tretinoin

      the gold standard retinoid in dermatology that's also helpful for hair regrowth alongside Minoxidil

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  40 upvotes 6 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community RU-58441 Janoshik test result of Made-In-China Supplier

      in Product  25 upvotes 2 months ago
      A user ordered RU58841 from a Chinese supplier, found it to be less than 99% pure, and plans to try a different seller next time. Concerns were raised about impurities, but the user believes they are likely inactive fillers rather than harmful substances.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  135 upvotes 1 year ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.